ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

KTTA Pasithea Therapeutics Corporation

6.92
0.00 (0.00%)
プレマーケット
最終更新日: 17:05:40
15分遅延
名称 銘柄コード 市場 種別
Pasithea Therapeutics Corporation KTTA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 6.92 17:05:40
始値 安値 高値 終値 前日終値
6.92
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2920:59GLOBEPasithea Therapeutics Announces PAS-004 Abstract Accepted..
2024/4/2420:59GLOBEPasithea Therapeutics Announces the First Cohort has..
2024/3/0211:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0211:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0211:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0211:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1321:59GLOBEPasithea Therapeutics Announces Opening of Enrollment in the..
2024/1/1906:30EDGAR2Form 8-K - Current report
2024/1/0821:59GLOBEPasithea Therapeutics Announces Invention of Crystalline..
2024/1/0306:47EDGAR2Form 8-K - Current report
2024/1/0222:35GLOBEPasithea Therapeutics Announces FDA Acceptance of IND..
2023/12/2907:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2907:00GLOBEPasithea Therapeutics Announces Adjournment of Reconvened..
2023/12/2901:30EDGAR2Form 8-K - Current report
2023/12/2007:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2007:21EDGAR2Form 8-K - Current report
2023/12/2007:19GLOBEPasithea Therapeutics Announces Results from 2023 Annual..
2023/12/1122:01GLOBEPasithea Therapeutics Announces Positive In Vivo Preclinical..
2023/11/3007:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/3006:27GLOBEPasithea Therapeutics Announces Adjournment of 2023 Annual..
2023/11/2921:59GLOBEPasithea Therapeutics Announces Outcome of Pre-IND Meeting..
2023/11/1406:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:59GLOBEPasithea Therapeutics Selects PAS-003 Lead Development..
2023/10/2706:01EDGAR2Form ARS - Annual Report to Security Holders
2023/10/2706:00EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/1706:18EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/10/1406:00EDGAR2Form 8-K - Current report
2023/9/1422:15EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/9/1422:11EDGAR2Form 8-K - Current report
2023/9/1421:30GLOBEPasithea Therapeutics Corp. Announces Final Results of..
2023/9/0805:14GLOBEPasithea Therapeutics to Participate in H.C. Wainwright 25th..
2023/8/2506:00EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/8/2206:22EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/8/1422:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/8/1206:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0922:08EDGAR2Form SC TO-I - Tender offer statement by Issuer
2023/8/0120:59GLOBEPasithea Therapeutics publishes study in Proceedings of the..
2023/7/2022:03EDGAR2Form SC TO-C - Written communication relating to an issuer..
2023/7/2021:56EDGAR2Form 8-K - Current report
2023/7/2021:43GLOBEPasithea Therapeutics Announces Intention to Commence a..
2023/7/2021:40GLOBEPasithea Therapeutics Special Committee Rejects Unsolicited..
2023/7/2021:31EDGAR2Form 8-K - Current report
2023/7/0406:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/6/3022:28GLOBEPasithea Therapeutics Confirms Previous Creation of..
2023/6/3003:50GLOBELucy Scientific Discovery Reiterates Its Proposal to Acquire..
2023/6/2921:29GLOBEPasithea Therapeutics Announces Completion of GMP..
2023/6/0705:30GLOBEPasithea Therapeutics Confirms Receipt of Unsolicited..
2023/6/0522:00GLOBELucy Scientific Discovery Announces Proposal to Acquire..
2023/6/0120:57GLOBEPasithea Therapeutics Abstract Accepted for Poster..

最近閲覧した銘柄

Delayed Upgrade Clock